BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6572097)

  • 1. Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia.
    Grever MR; Coleman MS; Balcerzak SP
    Cancer Res; 1983 Mar; 43(3):1442-5. PubMed ID: 6572097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
    Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
    Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on terminal deoxynucleotidyl transferase and adenosine deaminase in myasthenic thymus.
    Vezzoni P; Fiacchino F; Clerici L; Sghirlanzoni A; Cerrato D; Peluchetti D; Lucchini R; Raineri M; Cornelio F
    J Neuroimmunol; 1984; 6(6):427-33. PubMed ID: 6480820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
    Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
    J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenosine deaminase activity in leukemia patients].
    Müller G; Krug K; Richter V; Krüger W; Rassoul F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):763-8. PubMed ID: 6176499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biological marker model for predicting disease transitions.
    Klein JP; Klotz JH; Grever MR
    Biometrics; 1984 Dec; 40(4):927-36. PubMed ID: 6598390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Ph1-positive chronic myeloid leukemia blast crisis with a high level of terminal deoxynucleotidyl transferase responded to vincristine and prednisolone therapy (author's transl)].
    Nagai K; Nesumi N; Higashida M; Nagata I; Ueshima Y; Sawada H; Uchino H
    Rinsho Ketsueki; 1979 Sep; 20(9):1154-61. PubMed ID: 292803
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of the blastic crisis with terminal deoxynucleotidyl transferase positive blasts in chronic granulocytic leukemia.
    Sawada H; Tashima M; Konishi H; Usui T; Kita K; Oguma S; Kamada N; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):872-80. PubMed ID: 6949433
    [No Abstract]   [Full Text] [Related]  

  • 9. Purine degradative enzymes and terminal transferase in acute myelogenous leukemia: clinical relevance.
    Patmasiriwat P; Anukarahanonta T; Chinprasertsuk S
    Ann Clin Lab Sci; 1993; 23(4):281-9. PubMed ID: 8373133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine deaminase activity in hemoblastoses].
    Krüger W; Müller G; Storch H; Kubel M; Richter V
    Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis.
    Sarin PS; Virmani M; Gallo RC
    Int J Cancer; 1982 May; 29(5):501-6. PubMed ID: 6954135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.
    McCaffrey R; Harrison TA; Parkman R; Baltimore D
    N Engl J Med; 1975 Apr; 292(15):775-80. PubMed ID: 1054106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
    Schwarzmeier JD; Haas O; Paietta E; Fischer P
    Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of identification of TdT-positive cells by indirect immunofluorescence assay in bone marrow cells from patients with chronic myelogenous leukemia (author's transl)].
    Hida K; Sakamoto S; Kano Y; Tsuboyama A; Suda K; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1139-46. PubMed ID: 7036637
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia.
    Koya M; Kanoh T; Sawada H; Uchino H; Ueda K
    Blood; 1981 Dec; 58(6):1107-11. PubMed ID: 6272902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of terminal transferase and adenosine deaminase in leukemia.
    Brusamolino E; Bertazzoni U; Isernia P; Ginelli E; Scovassi AI; Zurlo MG; Plevani P; Sacchi N; Bernasconi C
    Adv Exp Med Biol; 1982; 145():279-303. PubMed ID: 7051780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular forms of adenosine deaminase in pleural effusions.
    Ungerer JP; Grobler SM
    Enzyme; 1988; 40(1):7-13. PubMed ID: 3168974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous evaluation for terminal deoxynucleotidyl transferase and myeloperoxidase in leukemia.
    Folds JD; Bollum FJ; Dean L; Chan J; Stass SA
    Am J Hematol; 1982 Jun; 12(4):391-6. PubMed ID: 6287839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.